High-Quality Screening and Target Validation During Drug Development

Drew Adams will discuss his work developing therapeutics that promote remyelination for neurological diseases.

Event Details:High-Quality Screening and Target Validation During Drug DevelopmentDate(s):

LIVE Webinar

Thursday, October 28, 2021
2:30 - 3:30 PM Eastern Time

Register Now

As scientists search for new drug targets and screen for compounds to treat disease, they often run into roadblocks related to data quality. Researchers must use their expertise to circumvent these problems if they hope to rapidly develop high-quality, novel therapeutics. In this webinar sponsored by Thermo Fisher Scientific, Drew Adams will discuss his work identifying new targets and screening small molecules to develop therapeutics for neurological diseases, with an emphasis on resolving data quality problems.

Topics to be covered

Register Now

Meet the Speaker:

Drew Adams, PhD
Thomas F. Peterson Professor of Novel Therapeutics
Associate Professor, Genetics and Genome Sciences
Director, Small Molecule Drug Development Core
Case Western Reserve University School of Medicine

Sponsored By

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
A greyscale image of cells dividing.
March 2025, Issue 1

How Do Embryos Know How Fast to Develop

In mammals, intracellular clocks begin to tick within days of fertilization.

View this Issue
Discover the history, mechanics, and potential of PCR.

Become a PCR Pro

Integra Logo
3D rendered cross section of influenza viruses, showing surface proteins on the outside and single stranded RNA inside the virus

Genetic Insights Break Infectious Pathogen Barriers

Thermo Fisher Logo
A photo of sample storage boxes in an ultra-low temperature freezer.

Navigating Cold Storage Solutions

PHCbi logo 
The Immunology of the Brain

The Immunology of the Brain

Products

Sapio Sciences

Sapio Sciences Makes AI-Native Drug Discovery Seamless with NVIDIA BioNeMo

DeNovix Logo

New DeNovix Helium Nano Volume Spectrophotometer

Olink Logo

Olink® Reveal: Accessible NGS-based proteomics for every lab

Olink logo
Zymo Logo

Zymo Research Launches the Quick-16S™ Full-Length Library Prep Kit